Back to News
Market Impact: 0.15
Jaguar Health Shares Jump As Napo Showcases Intestinal Failure Program At Abu Dhabi Conference
Source: Nasdaq
Healthcare & Biotech
Jaguar Health shares moved higher after it announced that subsidiary Napo Pharmaceuticals will sponsor an intestinal failure discussion at a pediatric gastroenterology meeting in Abu Dhabi on October 30. The article gives no share-price change or sponsorship value.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
Ticker Sentiment
JAGX0.30
More News
- Why is Telix Pharmaceuticals stock rallying today?
- Why is Natera stock sliding today?
- ArriVent BioPharma Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into ArriVent BioPharma (AVBP)
- Xenon Pharmaceuticals stock hits 52-week low at 36.06 USD
- McKesson and CD&R agree to acquire Option Care Health for $5.8 billion
- LQDA SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Liquidia Corporation
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Weekly Update: Advanced Search Filters, Redesigned Ticker Dashboard, and Improved Search Experience
- How to Build an Automated Research Process for a Fund